Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ekso Bionics Holdings, Inc. (NASDAQ: EKSO).

Full DD Report for EKSO

You must become a subscriber to view this report.


Recent News from (NASDAQ: EKSO)

Free Technical Snapshots for Ekso Bionics and Three More Medical Supplies Stocks
Stock Research Monitor: HAE, HRC, and NURO LONDON, UK / ACCESSWIRE / May 11, 2018/ If you want a free Stock Review on EKSO sign up now at www.wallstequities.com/registration . WallStEquities.com has initiated research coverage on Ekso Bionics Holdings Inc. (NASDAQ: EKSO ), Haemonet...
Source: ACCESSWIRE IA
Date: May, 11 2018 07:10
Ekso Bionics Holdings' (EKSO) CEO Jack Peurach on Q1 2018 Results - Earnings Call Transcript
Ekso Bionics Holdings (EKSO) Q1 2018 Earnings Conference Call May 07, 2018 04:30 PM ET Executives David Carey - IR Jack Peurach - President and CEO Max Scheder-Bieschin - CFO Analysts Stan Fediuk - SunTrust Presentation Operator Greetings and welcome to the Ekso B...
Source: SeekingAlpha
Date: May, 07 2018 22:37
Ekso Bionics Holdings misses by $0.02, misses on revenue
Ekso Bionics Holdings (NASDAQ: EKSO ): Q1 EPS of -$0.13 misses by $0.02 . More news on: Ekso Bionics Holdings, Inc., Earnings news and commentary, , Read more ...
Source: SeekingAlpha
Date: May, 07 2018 16:14
Ekso Bionics Reports First Quarter 2018 Results
RICHMOND, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2018. Recent Highlights and Accomplishments ...
Source: GlobeNewswire
Date: May, 07 2018 16:05
Ekso Bionics® to Report First Quarter 2018 Financial Results on May 7, 2018
RICHMOND, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2018 after the close of trad...
Source: GlobeNewswire
Date: April, 30 2018 08:00
Ekso surrenders bulk of "exciting news" spike; shares down 15%
Ekso Bionics Holdings ( EKSO -14.6% ) is down on average volume. Shares have retraced the lion's share of the  43%  spike on Monday after the company tweeted the pending release of "exciting news." More news on: Ekso Bionics Holdings, Inc., Healthcare stocks news, Stocks on the...
Source: SeekingAlpha
Date: March, 28 2018 13:20
Midday Gainers / Losers (3/28/2018)
ANW +29% . RH +23% . CLWT +19% . RSPP +16% . LHO +16% . SHPG +15% . AGX +15% . JNP +14% . LULU +12% . LLEX +11% . More news on: Aegean Marine Petroleum Network Inc., RH, Euro Tech Holdings Company Limited, , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: March, 28 2018 12:45
Premarket Losers as of 9:05 am (3/28/2018)
EDGE   -87%  on providing update following interim analysis of Phase 3 NEWTON 2 Study of EG-1962 in aSAH. More news on: Edge Therapeutics, InspireMD, Inc., Zosano Pharma, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: March, 28 2018 09:13
National Stroke Association and Ekso Bionics® Announce Educational Partnership to Advance Stroke Rehabilitation with Exoskeleton Technology
CENTENNIAL, Colo., and RICHMOND, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- National Stroke Association, a nonprofit that provides stroke education and programs to stroke survivors, caregivers, and the healthcare community, and Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader i...
Source: GlobeNewswire
Date: March, 27 2018 18:30
2 Health Sector Stocks To Watch As Biotech Market Rallies
CORAL GABLES, FL / ACCESSWIRE / March 27, 2018 / The biotechnology industry continues to recover this week. After having stumbled last week, along with the overall market, benchmarks based on the NASDAQ Biotechnology Index (IBB) continued to climb higher on Tuesday. Early premarket trading s...
Source: ACCESSWIRE IA
Date: March, 27 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-132.632.682.702.54587,290
2018-08-102.762.632.802.331,624,678
2018-08-092.452.752.752.412,940,061
2018-08-082.142.402.552.123,063,470
2018-08-072.102.332.401.9810,938,266

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-13109,746196,63255.8129Short
2018-08-10319,297605,52952.7303Short
2018-08-09777,6571,166,41666.6706Short
2018-08-08525,181974,78153.8768Short
2018-08-072,109,9773,168,86466.5846Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EKSO.


About Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)

Logo for Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)

Ekso Bionics is pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

 

 

 

Current Management

  • Thomas Looby / President, Interim CEO
  • Russ Angold / President, Subsidiary, Founder
  • Max SchederBieschin / CFO
  • Ofhir Agmon / Controller
  • Christopher Tagatac / IR
  • Steven Sherman / Chairman
  • David Daniel Boren /
  • Marilyn Hamilton /
  • Jack Peurach /
  • Stanley Stern /
  • Amy Wendell /

Current Share Structure

  • Market Cap: $110,211,477 - 03/09/2018
  • Authorized: 71,428,571 - 03/01/2018
  • Issue and Outstanding: 60,224,851 - 03/01/2018

 


Recent Filings from (NASDAQ: EKSO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 28 2018

 

 


Daily Technical Chart for (NASDAQ: EKSO)

Daily Technical Chart for (NASDAQ: EKSO)


Stay tuned for daily updates and more on (NASDAQ: EKSO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EKSO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EKSO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of EKSO and does not buy, sell, or trade any shares of EKSO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/